Strategic Research Institute Release: CNS Diseases Congress To Take Place March 27-28, 2006 In Boston, MA

BOSTON, Jan. 11 /PRNewswire/ -- The 2nd Annual "CNS Diseases Congress" will focus on recent advances in CNS Research & Development from major pharmaceutical & biotech companies as well as academia who are focused in the discovery of new drugs to treat psychiatric disorders & neurodegenerative diseases, announces Strategic Research Institute.

The 2 day event scheduled March 27-28, 2006 in Boston, MA will feature presentations from a variety of pharmaceutical, biotech, and academic leaders engaged in cutting edge work in the CNS field from early discovery through pre-clinical and clinical development. Companies such as Sanofi-Aventis, AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, Hoffmann-La Roche, Johnson & Johnson, Merck, Pfizer, Wyeth Research, Forest Laboratories, GlaxoSmithKline, Cephalon, Organon, DOV Pharmaceuticals and others will be present.

The congress is organized into 3 concurrent tracks which feature 3 annual events on Psychiatric Disorders, CNS Clinical Development and Alzheimer's Diseases. The agenda will feature over 45 presentations in two days which includes a senior management executive plenary session on day one and academic keynote presentations on day 2.

To receive a copy of the agenda, please contact Glenn Pascual at or call 212.967.0095, ext 245. Please include your name, title, company, and mailing address.

To become a conference sponsor or exhibitor, please contact Sandra Shlayan at

To inquire on how to become a media partner, please contact Cheryl Kahan-Radhuber at

Contact: Glenn A. Pascual Conference Producer, Life Sciences Strategic Research Institute 333 Seventh Avenue, 9th Floor New York, NY10001-5004 Tel: 212.967.0095, ext. 245 Fax: 212.967.7973 Email: Website:

Strategic Research Institute

CONTACT: Glenn A. Pascual, Conference Producer, Life Sciences of StrategicResearch Institute, +1-212-967-0095, ext. 245, or Fax, +1-212-967-7973,

Back to news